WHO vaccine-preventable diseases: monitoring system. 2015 global summary

Last updated 28-May-2015 (Data received as of 22-May-2015)
Next overall update July 2015
2014 data are provisional
EPI mother and child logo         
Select a country

Development status: Developed economy GNI / capita (US$): 1 Infant (under 12 months) mortality rate: 62
GDP / capita (US$): 1 Child (under 5 years) mortality rate: 82

Population data in thousands3

  2014  2013  2012  2011  2010  2000  1990  1980 
Total population 5'454  5'450  5'446  5'440  5'433  5'388  5'278  4'989 
Births 58  58  58  58  58  54  80  97 
Surviving infants 58  58  58  58  57  53  79  95 
Pop. less than 5 years 290  291  292  289  282  288  414  485 
Pop. less than 15 years 824  821  819  820  822  1'062  1'340  1'303 
Female 15-49 years 1'369  1'380  1'391  1'401  1'411  1'448  1'324  1'230 

Number of reported case

(Click for retrospective incidence data for Slovakia)
Diphtheria
Japanese encephalitis
Measles 47 
Mumps 1'559  218  32 
Pertussis 1'123  907  950  936  1'379  43  194 
Polio*
Rubella 11 
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)**
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Slovakia)
Vaccine year result method % card seen                                                
BCG          90  97  98  94 
DTP1          99 
DTP3          97  98  99  99  99  99 
HepB_BD          99*  99* 
HepB3          97  98  99  99  99  98 
Hib3          97  98  99  99  99 
JapEnc         
MCV          97  98  99  98  99  98 
MCV2          98  99  99  99  99  99 
PCV1         
PCV3          97  98  99  99  99 
Pol3          97  98  99  99  99  98 
Rota1         
Rota_last         
Rubella1          97  98  99  98  99 
TT2plus         
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Slovakia)
BCG 90  90  97  98  94 
DTP1 99  99  99  99  99 
DTP3 98  99  99  99  99 
HepB3 98  99  99  99  98 
HepB_BD
Hib3 98  99  99  99  59 
MCV 98  99  98  98  98 
MCV2 99  99  99  99  99 
PCV3 98  99  99  99 
Pol3 98  99  99  99  98 
Rota_last

Number of districts in the country 79  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 100
From 80 to 89% 0
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2014 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
DTaPHibHepIPV 2, 4, 10 months; Yes
DTaPIPV 5, 12 years; Yes
HepB birth; Yes newborns of HBSaG positive mothers;
Influenza_Adult >= 59 years; Yes and adults with chronic diseases. Health care workers, and other risk groups
Influenza_Pediatric 6 months to 12 years; Yes and children with chronic diseases
MMR 14 months; 10 years; Yes
Pneumo_conj 2, 4, 10 months; Yes
Td Yes revaccination of adults each 15 years

Immunizaton indicators

Indicator Expected answer 2014  2013  2012  2011  2010  2009  2008 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number   not specified      not specified  2009-2010  2008-2010 
Nº of districts with microplans that include activities to raise immunization coverage number 79  79  79  79  79  79  79 

System performance

Total Nº districts in country number 79  79  79  79  79  79  79 
Nº districts with DTP3 coverage >=80% number 79  79  79  79  79  79  79 
% of districts with DTP3 coverage >=80% From 0 to 100% 100  100  100  100  100  100  100 
Nº districts with measles (MCV1) coverage >=95% number 68  73  79  79  79  79  79 
% of districts with MCV1 coverage >=95% From 0 to 100% 86  92  100  100  100  100  100 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  NA  No  No     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100%   100  100  100  100  NA  NA 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes     

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.